List of Excipients in API metoclopramide
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing metoclopramide
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| ANI Pharmaceuticals Inc | METOCLOPRAMIDE | metoclopramide | 62559-295 | ALUMINUM OXIDE | |
| ANI Pharmaceuticals Inc | METOCLOPRAMIDE | metoclopramide | 62559-295 | ANHYDROUS LACTOSE | |
| ANI Pharmaceuticals Inc | METOCLOPRAMIDE | metoclopramide | 62559-295 | CELLULOSE, MICROCRYSTALLINE | |
| ANI Pharmaceuticals Inc | METOCLOPRAMIDE | metoclopramide | 62559-295 | D&C YELLOW NO. 10 | |
| ANI Pharmaceuticals Inc | METOCLOPRAMIDE | metoclopramide | 62559-295 | FD&C BLUE NO. 1 | |
| ANI Pharmaceuticals Inc | METOCLOPRAMIDE | metoclopramide | 62559-295 | SILICON DIOXIDE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing metoclopramide
Detailed excipient profiles for metoclopramide
Excipient focus: ALUMINUM OXIDE
metoclopramide drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | metoclopramide | 62559-295 |
| Rebel Distributors Corp | metoclopramide hydrochloride | 42254-196 |
| ANI Pharmaceuticals Inc | metoclopramide hydrochloride | 62559-165 |
| >Company | >Ingredient | >NDC |
metoclopramide drug variants not containing ALUMINUM OXIDE
Excipient focus: ANHYDROUS CITRIC ACID
metoclopramide drug variants containing ANHYDROUS CITRIC ACID
metoclopramide drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
metoclopramide drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
metoclopramide drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Excipient focus: ANHYDROUS LACTOSE
metoclopramide drug variants containing ANHYDROUS LACTOSE
metoclopramide drug variants not containing ANHYDROUS LACTOSE
Excipient focus: ASPARTAME
metoclopramide drug variants containing ASPARTAME
| Company | Ingredient | NDC |
|---|---|---|
| Novel Laboratories Inc | metoclopramide hydrochloride | 40032-580 |
| Lupin PharmaceuticalsInc | metoclopramide hydrochloride | 43386-580 |
| >Company | >Ingredient | >NDC |
metoclopramide drug variants not containing ASPARTAME
Excipient focus: BENZALKONIUM CHLORIDE
metoclopramide drug variants containing BENZALKONIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Evoke Pharma Inc | metoclopramide hydrochloride | 72089-307 |
| >Company | >Ingredient | >NDC |
metoclopramide drug variants not containing BENZALKONIUM CHLORIDE
Excipient focus: BUTYLATED HYDROXYANISOLE
metoclopramide drug variants containing BUTYLATED HYDROXYANISOLE
| Company | Ingredient | NDC |
|---|---|---|
| Novel Laboratories Inc | metoclopramide hydrochloride | 40032-580 |
| Lupin PharmaceuticalsInc | metoclopramide hydrochloride | 43386-580 |
| >Company | >Ingredient | >NDC |
metoclopramide drug variants not containing BUTYLATED HYDROXYANISOLE
Excipient focus: BUTYLATED HYDROXYTOLUENE
metoclopramide drug variants containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| Novel Laboratories Inc | metoclopramide hydrochloride | 40032-580 |
| Lupin PharmaceuticalsInc | metoclopramide hydrochloride | 43386-580 |
| >Company | >Ingredient | >NDC |
metoclopramide drug variants not containing BUTYLATED HYDROXYTOLUENE
Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
metoclopramide drug variants containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
metoclopramide drug variants not containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
Excipient focus: CELLULOSE, MICROCRYSTALLINE
metoclopramide drug variants containing CELLULOSE, MICROCRYSTALLINE
metoclopramide drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CITRIC ACID MONOHYDRATE
metoclopramide drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Atlantic Biologicals Corps | metoclopramide hydrochloride | 17856-0576 |
| Atlantic Biologicals Corps | metoclopramide hydrochloride | 17856-3727 |
| Unit Dose Services | metoclopramide hydrochloride | 50436-0576 |
| Evoke Pharma Inc | metoclopramide hydrochloride | 72089-307 |
| >Company | >Ingredient | >NDC |
metoclopramide drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: COLLOIDAL SILICON DIOXIDE
metoclopramide drug variants containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | metoclopramide | 54868-1873 |
| Ranbaxy Pharmaceuticals Inc | metoclopramide | 63304-845 |
| >Company | >Ingredient | >NDC |
metoclopramide drug variants not containing COLLOIDAL SILICON DIOXIDE
Excipient focus: CROSPOVIDONE
metoclopramide drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Novel Laboratories Inc | metoclopramide hydrochloride | 40032-580 |
| Lupin PharmaceuticalsInc | metoclopramide hydrochloride | 43386-580 |
| >Company | >Ingredient | >NDC |
metoclopramide drug variants not containing CROSPOVIDONE
Excipient focus: D&C YELLOW NO. 10
metoclopramide drug variants containing D&C YELLOW NO. 10
metoclopramide drug variants not containing D&C YELLOW NO. 10
Excipient focus: DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER
metoclopramide drug variants containing DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Novel Laboratories Inc | metoclopramide hydrochloride | 40032-580 |
| Lupin PharmaceuticalsInc | metoclopramide hydrochloride | 43386-580 |
| >Company | >Ingredient | >NDC |
metoclopramide drug variants not containing DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER
Excipient focus: EDETATE DISODIUM
metoclopramide drug variants containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Evoke Pharma Inc | metoclopramide hydrochloride | 72089-307 |
| >Company | >Ingredient | >NDC |
metoclopramide drug variants not containing EDETATE DISODIUM
Excipient focus: FD&C BLUE NO. 1
metoclopramide drug variants containing FD&C BLUE NO. 1
metoclopramide drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C RED NO. 40
metoclopramide drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| American Health Packaging | metoclopramide | 60687-837 |
| ANI Pharmaceuticals Inc | metoclopramide | 62559-190 |
| Bryant Ranch Prepack | metoclopramide | 63629-1961 |
| Bryant Ranch Prepack | metoclopramide | 63629-2144 |
| Bryant Ranch Prepack | metoclopramide | 72162-1750 |
| >Company | >Ingredient | >NDC |
metoclopramide drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 5
metoclopramide drug variants containing FD&C YELLOW NO. 5
| Company | Ingredient | NDC |
|---|---|---|
| American Health Packaging | metoclopramide | 60687-837 |
| ANI Pharmaceuticals Inc | metoclopramide | 62559-190 |
| Bryant Ranch Prepack | metoclopramide | 63629-1961 |
| Bryant Ranch Prepack | metoclopramide | 63629-2144 |
| Bryant Ranch Prepack | metoclopramide | 72162-1750 |
| >Company | >Ingredient | >NDC |
metoclopramide drug variants not containing FD&C YELLOW NO. 5
Excipient focus: FD&C YELLOW NO. 6
metoclopramide drug variants containing FD&C YELLOW NO. 6
metoclopramide drug variants not containing FD&C YELLOW NO. 6
Excipient focus: GLYCERIN
metoclopramide drug variants containing GLYCERIN
metoclopramide drug variants not containing GLYCERIN
Excipient focus: HYDROCHLORIC ACID
metoclopramide drug variants containing HYDROCHLORIC ACID
metoclopramide drug variants not containing HYDROCHLORIC ACID
Excipient focus: LACTOSE MONOHYDRATE
metoclopramide drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| STAT RX USA LLC | metoclopramide hydrochloride | 16590-150 |
| >Company | >Ingredient | >NDC |
metoclopramide drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
metoclopramide drug variants containing MAGNESIUM STEARATE
metoclopramide drug variants not containing MAGNESIUM STEARATE
Excipient focus: MANNITOL
metoclopramide drug variants containing MANNITOL
metoclopramide drug variants not containing MANNITOL
Excipient focus: METHYLPARABEN
metoclopramide drug variants containing METHYLPARABEN
metoclopramide drug variants not containing METHYLPARABEN
Excipient focus: PHOSPHORIC ACID
metoclopramide drug variants containing PHOSPHORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Novel Laboratories Inc | metoclopramide hydrochloride | 40032-580 |
| Lupin PharmaceuticalsInc | metoclopramide hydrochloride | 43386-580 |
| >Company | >Ingredient | >NDC |
metoclopramide drug variants not containing PHOSPHORIC ACID
Excipient focus: POVIDONE
metoclopramide drug variants containing POVIDONE
metoclopramide drug variants not containing POVIDONE
Excipient focus: POVIDONES
metoclopramide drug variants containing POVIDONES
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | metoclopramide hydrochloride | 42254-266 |
| State of Florida DOH Central Pharmacy | metoclopramide hydrochloride | 53808-0623 |
| >Company | >Ingredient | >NDC |
metoclopramide drug variants not containing POVIDONES
Excipient focus: PROPYLENE GLYCOL
metoclopramide drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | metoclopramide hydrochloride | 62135-526 |
| >Company | >Ingredient | >NDC |
metoclopramide drug variants not containing PROPYLENE GLYCOL
Excipient focus: PROPYLPARABEN
metoclopramide drug variants containing PROPYLPARABEN
metoclopramide drug variants not containing PROPYLPARABEN
Excipient focus: SACCHARIN SODIUM
metoclopramide drug variants containing SACCHARIN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | metoclopramide hydrochloride | 62135-526 |
| >Company | >Ingredient | >NDC |
metoclopramide drug variants not containing SACCHARIN SODIUM
Excipient focus: SILICON DIOXIDE
metoclopramide drug variants containing SILICON DIOXIDE
metoclopramide drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM CHLORIDE
metoclopramide drug variants containing SODIUM CHLORIDE
metoclopramide drug variants not containing SODIUM CHLORIDE
Excipient focus: SODIUM HYDROXIDE
metoclopramide drug variants containing SODIUM HYDROXIDE
metoclopramide drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
metoclopramide drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
metoclopramide drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: SORBITOL
metoclopramide drug variants containing SORBITOL
metoclopramide drug variants not containing SORBITOL
Excipient focus: STARCH, CORN
metoclopramide drug variants containing STARCH, CORN
metoclopramide drug variants not containing STARCH, CORN
Excipient focus: STEARIC ACID
metoclopramide drug variants containing STEARIC ACID
metoclopramide drug variants not containing STEARIC ACID
Excipient focus: TRISODIUM CITRATE DIHYDRATE
metoclopramide drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Evoke Pharma Inc | metoclopramide hydrochloride | 72089-307 |
| >Company | >Ingredient | >NDC |
metoclopramide drug variants not containing TRISODIUM CITRATE DIHYDRATE
Excipient focus: WATER
metoclopramide drug variants containing WATER
metoclopramide drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
